Vitamin & Supplement Sources
Here is a list of supplements and vitamins I use to help fight ME/CFS and to prevent
I'm continuously experimenting with various combinations of supplements to combat ME/CFS.
Here is my current list:
Here is a link to the Vitamin Supply company I use most often:
(Click on the banner below)
The reason I use Puritan's Pride, is because of their commitment to quality and low prices.
They have all their ingredients inspected at their own lab and also have third party labs do audits. They
also have great formulations for specific needs. Click on the banner I posted above and then check out come
of the products and prices.
Or type in your favorite supplement ( eg. astaxanthin ) in this search box to see what
Puritan's Pride is selling it for:
Another company that I use quite often for nutritional supplements and advice specific to ME/CFS ,
Pain, and general Aging prevention is "Pro Health" .
10% Off + Free Shipping on Your Order of
I like Pro Health because they offer prescription quality supplements at a reasonable price. That way you
know you are getting full value from any item you order. Also they donate a percentage of profits to ongoing
research charities. And lastly, they have active member forums which will tell you which products are working
in real people's lives, not just some rat in a lab.
Pro Health has some of the highest quality protein powders for the lowest price I've found.
If you are concerned about alzheimer's disease, you might want to explore this product. For some strange
reason, Health Canada has banned the sales of all single amino acids, so it is difficult to get in
Note that some studies have shown that as little as 500mg/day of ALC are needed to show a benefit in
mild memory disfunction.
Effects of Acetyl-L-Carnitine In Alzheimer's Disease Patients Unresponsive to Acetylcholinesterase
(ALC) is a compound acting as an intracellular carrier of acetyl groups across inner mitochondrial membranes.
It also appears to have neuroprotective properties and it has recently been shown to reduce attention deficits
in patients with Alzheimer's disease (AD) after long-term treatment. We performed an open study to evaluate
the effect of ALC (2 g/day orally for 3 months) in association with donepezil or rivastigmine in 23 patients
with mild AD who had not responded to treatment with acetylcholinesterase inhibitors (AChE-I). Clinical
effects were evaluated by assessing cognitive functions, functional status and behavioural symptoms. The
response rate, which was 38% after AChE-I treatment, increased to 50% after the addition of ALC, indicating
that the combination of these two drugs may be a useful therapeutic option in AD patients. These data do not
permit a conclusion as to the possible mechanism of action of the association of the two treatments.